| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.039 | 0.8 |